We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+4.9%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
AUM
$3.9B
AUM Growth
+$213M
Cap. Flow
+$75.8M
Cap. Flow %
1.94%
Top 10 Hldgs %
36.05%
Holding
3,497
New
199
Increased
1,347
Reduced
1,062
Closed
172

Sector Composition

Rank Sector Weight
1 Technology 16.58%
2 Healthcare 8.56%
3 Financials 6.53%
4 Communication Services 5.05%
5 Consumer Discretionary 4.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IXN icon
26
iShares Global Tech ETF
IXN
$8.83B
$21.3M 0.55%
257,711
+2,688
+1% +$205K
QQQ icon
27
Invesco QQQ Trust
QQQ
$484B
$21.3M 0.55%
44,472
-1,827
-4% -$822K
UBER icon
28
Uber
UBER
$153B
$19.4M 0.5%
267,099
+1,792
+0.7% +$125K
V icon
29
Visa
V
$677B
$19.4M 0.5%
73,829
+2,519
+4% +$690K
ADBE icon
30
Adobe
ADBE
$105B
$19.3M 0.49%
34,747
+645
+2% +$312K
IEMG icon
31
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
$19M 0.49%
355,120
+13,361
+4% +$705K
ABBV icon
32
AbbVie
ABBV
$435B
$18.9M 0.48%
110,107
-1,340
-1% -$222K
SPY icon
33
State Street SPDR S&P 500 ETF Trust
SPY
$823B
$18.3M 0.47%
33,665
-589
-2% -$308K
MA icon
34
Mastercard
MA
$493B
$18M 0.46%
40,877
-1,086
-3% -$495K
VCIT icon
35
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.3B
$18M 0.46%
224,789
-784
-0.3% -$62.2K
UNH icon
36
UnitedHealth
UNH
$370B
$18M 0.46%
35,278
-105
-0.3% -$51.5K
TMO icon
37
Thermo Fisher Scientific
TMO
$220B
$17.7M 0.45%
32,064
+750
+2% +$430K
CVX icon
38
Chevron
CVX
$366B
$17.6M 0.45%
112,611
-436
-0.4% -$69.5K
ACN icon
39
Accenture
ACN
$108B
$17.4M 0.45%
57,511
-301
-0.5% -$92.2K
SCHD icon
40
Schwab US Dividend Equity ETF
SCHD
$105B
$17.2M 0.44%
663,867
-48,072
-7% -$1.25M
SPTM icon
41
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$14B
$17.2M 0.44%
258,811
-14,130
-5% -$905K
JMBS icon
42
Janus Henderson Mortgage-Backed Securities ETF
JMBS
$6.73B
$17.1M 0.44%
382,707
+43,917
+13% +$1.95M
CRM icon
43
Salesforce
CRM
$158B
$17M 0.44%
66,129
+300
+0.5% +$80.3K
EFA icon
44
iShares MSCI EAFE ETF
EFA
$80.2B
$16.1M 0.41%
205,431
-7,716
-4% -$611K
PLTR icon
45
Palantir
PLTR
$413B
$15.9M 0.41%
627,415
+1,701
+0.3% +$38.3K
ISRG icon
46
Intuitive Surgical
ISRG
$134B
$15.9M 0.41%
35,688
-105
-0.3% -$41.8K
VOO icon
47
Vanguard S&P 500 ETF
VOO
$1.01T
$15.7M 0.4%
31,435
+523
+2% +$252K
IDV icon
48
iShares International Select Dividend ETF
IDV
$8.51B
$15.5M 0.4%
558,811
-50,355
-8% -$1.43M
NFLX icon
49
Netflix
NFLX
$309B
$15.3M 0.39%
227,200
+15,800
+7% +$987K
INTU icon
50
Intuit
INTU
$89B
$15.1M 0.39%
22,986
-116
-0.5% -$72K

Similar funds

Parallel Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Parallel Advisors held 3,497 positions worth $3.9B, up 5.8% from $3.69B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Parallel Advisors's Q2 2024 filing shows 199 new, 1,347 increased, 1,062 reduced and 172 closed positions. Its largest new stake was BlackRock Flexible Income ETF: 24,596 shares worth $1.28M. The largest sale was iShares MSCI USA Quality Factor ETF, an estimated $52.1M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

  • Parallel Advisors's largest Q2 2024 buy was BlackRock Flexible Income ETF: 24,596 shares worth $1.28M.
  • Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $79.4M increase.
  • Parallel Advisors's biggest Q2 2024 reduction was iShares MSCI USA Quality Factor ETF, cutting an estimated $52.1M.
  • Parallel Advisors fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $974K.
  • Parallel Advisors's ten largest holdings make up 36% of its $3.9B portfolio in Q2 2024.
  • Parallel Advisors opened 199 new positions and closed 172 in Q2 2024.
  • Parallel Advisors's portfolio value rose 5.8% quarter-over-quarter to $3.9B.

Based on Parallel Advisors's 13F filing for Q2 2024, filed 8 Aug 2024.